Researcher.Life Logo

Cancer Management and Research : Impact Factor & More

eISSN: 1179-1322pISSN: 1179-1322
JournalOpen Access

Key Metrics

CiteScore
5.4
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
SJR
Q3Oncology
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Management and Research

Cancer Management and Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2410
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Cancer Management and Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Management and Research

Factors Influencing Survival After Curative Gastrectomy in Oligometastatic Gastric Cancer: A Single-Center Study
  • 13 May 2026
  • Cancer Management and Research
TNFAIP3 Reprograms T Cell Exhaustion and Restores Anti-Leukemia Immunity in Acute Myeloid Leukemia
  • 13 May 2026
  • Cancer Management and Research
Long Non-Coding RNA SNHG14 Impedes Viability, Migration and Invasion of Endometrial Carcinoma Cells Through Modulating miR-93-5p/ZBTB7A\xa0Axis [Retraction]
  • 13 May 2026
  • Cancer Management and Research
LncRNA WT1-AS Inhibits the Aggressiveness of Cervical Cancer Cell via Regulating p53 Expression via Sponging miR-330-5p [Retraction]
  • 12 May 2026
  • Cancer Management and Research
Advances in Phase III Clinical Trials and Future Challenges of Targeted Therapy in Advanced Ovarian Cancer
  • 12 May 2026
  • Cancer Management and Research
SLC2A3 Expression is Differentially Associated with Postoperative Recurrence, Complications, and Liver Metastasis in Colorectal Cancer
  • 8 May 2026
  • Cancer Management and Research
Factors Influencing Survival After Curative Gastrectomy in Oligometastatic Gastric Cancer: A Single-Center Study
  • 13 May 2026
  • Cancer Management and Research
TNFAIP3 Reprograms T Cell Exhaustion and Restores Anti-Leukemia Immunity in Acute Myeloid Leukemia
  • 13 May 2026
  • Cancer Management and Research
Long Non-Coding RNA SNHG14 Impedes Viability, Migration and Invasion of Endometrial Carcinoma Cells Through Modulating miR-93-5p/ZBTB7A\xa0Axis [Retraction]
  • 13 May 2026
  • Cancer Management and Research
LncRNA WT1-AS Inhibits the Aggressiveness of Cervical Cancer Cell via Regulating p53 Expression via Sponging miR-330-5p [Retraction]
  • 12 May 2026
  • Cancer Management and Research
Advances in Phase III Clinical Trials and Future Challenges of Targeted Therapy in Advanced Ovarian Cancer
  • 12 May 2026
  • Cancer Management and Research
SLC2A3 Expression is Differentially Associated with Postoperative Recurrence, Complications, and Liver Metastasis in Colorectal Cancer
  • 8 May 2026
  • Cancer Management and Research

FAQs on Cancer Management and Research